SenesTech (NASDAQ:SNES) Coverage Initiated at StockNews.com

StockNews.com started coverage on shares of SenesTech (NASDAQ:SNESFree Report) in a research report sent to investors on Saturday morning. The brokerage issued a sell rating on the stock.

SenesTech Stock Down 6.3 %

Shares of SNES traded down $0.19 on Friday, hitting $2.84. 7,357 shares of the stock traded hands, compared to its average volume of 39,164. SenesTech has a one year low of $1.90 and a one year high of $45.60. The business has a 50 day simple moving average of $2.71 and a 200 day simple moving average of $4.76. The company has a debt-to-equity ratio of 0.05, a current ratio of 4.68 and a quick ratio of 3.49.

SenesTech (NASDAQ:SNESGet Free Report) last posted its earnings results on Thursday, August 8th. The company reported ($3.08) EPS for the quarter, topping analysts’ consensus estimates of ($3.20) by $0.12. The business had revenue of $0.46 million during the quarter, compared to analyst estimates of $0.49 million. SenesTech had a negative return on equity of 168.64% and a negative net margin of 464.09%. During the same quarter last year, the company earned ($84.03) EPS. On average, equities analysts forecast that SenesTech will post -11 EPS for the current year.

SenesTech Company Profile

(Get Free Report)

SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.

Further Reading

Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.